Jove
Visualize
Contact Us

Related Concept Videos

Necrosis01:16

Necrosis

5.3K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
5.3K
Cellular Adaptation IV: Dysplasia and Metaplasia01:24

Cellular Adaptation IV: Dysplasia and Metaplasia

70
DysplasiaDysplasia refers to abnormal changes in the size, shape, and organization of mature cells, characterized by pleomorphism, nuclear abnormalities, and increased mitotic activity. It commonly affects epithelial tissues, including the cervix, gastrointestinal tract, respiratory mucosa, and endometrium. Although it may occur alongside hyperplasia, dysplasia is not a true adaptive response but a preneoplastic change with potential to progress to cancer.When confined above the basement...
70
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

9.2K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.2K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

6.1K
6.1K
Tumor Progression02:07

Tumor Progression

3.2K
3.2K
Tumor Progression02:07

Tumor Progression

6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of Iron Accumulation in Osteoporosis and the Underlying Mechanisms.

Current medical science·2023
Same author

The influence of various sources of nitrogen on the activity of antibiotics.

Antibiotics & chemotherapy (Northfield, Ill.)·2014
Same author

The influence of inorganic salts on the activity in vitro of oxytetracycline.

Antibiotics & chemotherapy (Northfield, Ill.)·2014
Same author

Dietary and prophylactic iron supplements : Helpful or harmful?

Human nature (Hawthorne, N.Y.)·2013
Same author

Can iron be teratogenic?

Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine·2009
Same author

First trimester curtailment of iron absorption: innate suppression of a teratogen?

Medical hypotheses·2009
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 5, 2026

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism
05:36

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism

Published on: February 23, 2024

1.0K

Iron and neoplasia.

E D Weinberg1

  • 1Department of Biology (College of Arts & Sciences) and Program in Medical Sciences (School of Medicine), Indiana University, 47405, Bloomington, IN.

Biological Trace Element Research
|November 26, 2013
PubMed
Summary
This summary is machine-generated.

Neoplastic cells, like pathogenic microbes, may exploit iron differently, impacting host defenses. Understanding iron metabolism in cancer could lead to new therapeutic strategies.

More Related Videos

Biofunctionalization of Magnetic Nanomaterials
06:40

Biofunctionalization of Magnetic Nanomaterials

Published on: July 16, 2020

4.1K
Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining
07:32

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining

Published on: May 23, 2025

1.5K

Related Experiment Videos

Last Updated: May 5, 2026

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism
05:36

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism

Published on: February 23, 2024

1.0K
Biofunctionalization of Magnetic Nanomaterials
06:40

Biofunctionalization of Magnetic Nanomaterials

Published on: July 16, 2020

4.1K
Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining
07:32

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining

Published on: May 23, 2025

1.5K

Area of Science:

  • Oncology
  • Microbiology
  • Immunology

Background:

  • Neoplastic cells share similarities with pathogenic microorganisms in iron requirements and acquisition.
  • Altered iron acquisition mechanisms in neoplastic cells may facilitate growth in iron-limited host environments.
  • Both iron excess and deficiency can negatively impact host defenses and cellular health.

Purpose of the Study:

  • To explore the parallels between neoplastic cells and pathogenic microorganisms regarding iron metabolism.
  • To investigate the role of iron in host defense against cancer.
  • To assess the potential for manipulating iron metabolism as an adjunct cancer therapy.

Main Methods:

  • Comparative analysis of iron handling in normal, neoplastic, and microbial cells.
  • Review of existing literature on iron overload and neoplasm development.
  • Discussion of the potential for constructing animal models of iron overload.

Main Results:

  • Neoplastic cells may possess distinct iron acquisition strategies, similar to pathogenic microbes.
  • Excess iron can compromise host immunity against malignant cells.
  • Elevated temperatures show differential toxicity towards neoplastic versus normal cells, with potential links to iron acquisition.

Conclusions:

  • Iron dysregulation is a critical factor in cancer development and progression.
  • Further research, including animal models, is needed to understand host nutritional immunity against cancer.
  • Therapeutic strategies targeting iron metabolism could enhance conventional cancer treatments like radiotherapy and chemotherapy.